
EXELIXIS, INC.
EXELIXIS, INC. (EXEL)
WebsitePrice
Market cap
Next catalystExpected 2026XB773 — pre-IND development · Trial initiationCompany source ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved
Other pipelines
Partner / License out
Approved / commercial
History / paused
Financial position
Upcoming milestones
Financial history
Annual trends
| Reported item | ||||
|---|---|---|---|---|
Reported shares and borrowings
Ownership and institutions
| Status | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|